Evidence map›Paper›PMID 33820739›Full record

ArticleJournal of genetics and genomics = Yi chuan xue bao2021

Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene.

Paul D Hartley, Richard L Tillett, David P AuCoin, Joel R Sevinsky, Yanji Xu, Andrew Gorzalski, Mark Pandori, Erin Buttery, Holly Hansen, Michael A Picker and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of genetics and genomics = Yi chuan xue bao, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Paul D HartleyNevada Genomics Center, Reno, NV 89557, USA; University of Nevada, Reno, Reno, NV 89557, USA.
Richard L TillettNevada Institute of Personalized Medicine, University of Nevada, Las Vegas, NV 89154, USA.
David P AuCoinUniversity of Nevada, Reno, Reno, NV 89557, USA; Department of Microbiology & Immunology, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA.
Joel R SevinskyTheiagen Consulting, LLC, Highlands Ranch, CO 80128, USA.
Yanji XuUniversity of Nevada, Reno, Reno, NV 89557, USA; Nevada Center for Bioinformatics, Reno, NV 89557, USA.
Andrew GorzalskiUniversity of Nevada, Reno, Reno, NV 89557, USA; Nevada State Public Health Laboratory, Reno, NV 89503, USA.
Mark PandoriUniversity of Nevada, Reno, Reno, NV 89557, USA; Nevada State Public Health Laboratory, Reno, NV 89503, USA.
Erin ButterySouthern Nevada Public Health Laboratory of the Southern Nevada Health District, Las Vegas, NV 89107, USA.
Holly HansenSouthern Nevada Public Health Laboratory of the Southern Nevada Health District, Las Vegas, NV 89107, USA.
Michael A PickerSouthern Nevada Public Health Laboratory of the Southern Nevada Health District, Las Vegas, NV 89107, USA.
Cyprian C RossettoUniversity of Nevada, Reno, Reno, NV 89557, USA; Department of Microbiology & Immunology, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA. Electronic address: crossetto@med.unr.edu.
Subhash C VermaUniversity of Nevada, Reno, Reno, NV 89557, USA; Department of Microbiology & Immunology, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA. Electronic address: scverma@med.unr.edu.
University of Nevada, Reno · USSouthern Nevada Health District · USUniversity of Nevada, Las Vegas · US

Funding

Outreach/Diversity/Pipeline ProjectP20GM103440 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Eduardo A Robleto · 2012 to 2026
$58.0M
Tracking and EvaluationU54GM104944 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI KUMAR, PARVESH · 2013 to 2023
$39.6M
NIGMS NIH HHS P20 GM103440NIGMS NIH HHS U54 GM104944
6 · The paper itself

Abstract

Patients with signs of COVID-19 were tested through diagnostic RT-PCR for SARS-CoV-2 using RNA extracted from the nasopharyngeal/nasal swabs. To determine the variants of SARS-CoV-2 circulating in the state of Nevada, specimens from 200 COVID-19 patients were sequenced through our robust sequencing platform, which enabled sequencing of SARS-CoV-2 from specimens with even very low viral loads, without the need of culture-based amplification. High genome coverage allowed the identification of single and multi-nucleotide variants in SARS-CoV-2 in the community and their phylogenetic relationships with other variants present during the same period of the outbreak. We report the occurrence of a novel mutation at 323aa (314aa of orf1b) of nsp12 (RNA-dependent RNA polymerase) changed to phenylalanine (F) from proline (P), in the first reported isolate of SARS-CoV-2, Wuhan-Hu-1. This 323F variant was present at a very high frequency in Northern Nevada. Structural modeling determined this mutation in the interface domain, which is important for the association of accessory proteins required for the polymerase. In conclusion, we report the introduction of specific SARS-CoV-2 variants at very high frequency in distinct geographic locations, which is important for understanding the evolution and circulation of SARS-CoV-2 variants of public health importance, while it circulates in humans.

Indexed as

Coronavirus RNA-Dependent RNA PolymeraseCOVID-19Genome, ViralHumansModels, MolecularMutationNasopharynxNevadaPhylogenyPrevalenceRNA, ViralSARS-CoV-2Spike Glycoprotein, CoronavirusWorkflowCoronavirus RNA-Dependent RNA PolymeraseNSP12 protein, SARS-CoV-2RNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19Genome enrichmentnsp12orf1b 314RdRpSARS-CoV-2

Identifiers

PMID33820739
PMCPMC7891100
OpenAlexW3132439172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.